NVTA Invitae Corp.

21.790.11 (+0.51%)
Close: September 16, 2019

Quote

Previous Close
$21.79
Day Range
$21.25-$21.95
52 Week Range
$9.04-$28.75
Volume
1,283,516
Avg Volume
2,594,667
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$2.07B
Enterprise Value (EV)
$2.02B
PE Ratio
-
EV/EBITDA
-19.21
Price/Sales
13.97
Price/Book
12.81
PEG Ratio
-

Financials

Revenue
$147.70M
Gross Profit
$67.59M
EBITDA
-$104.90M
EPS, ttm
-$1.86
Profit Margin
-
Revenue/Employee
$187.44K
Next Earnings Date
11/11/2019 (55 days)
Debt to Equity
48%
Debt
$67.32M
Cash
$125.89M
Net Debt
-

Performance

Beta
2.25
200 Day Moving Avg
$19.92
50 Day Moving Avg
$24.20
52 Week Change
31.90%
YTD Change
92.20%
1 Month Change
-13.87%
3 Month Change
5.65%
6 Month Change
-10.38%
1 Year Change
31.23%
2 Year Change
132.10%
5 Year Change
46.74%

Share Count

Shares Outstanding
95.2M
Float
90.5M
Restricted Shares
4.7M
Restricted Shares, %
4.92%

Invitae Corp. Company Details

Sector: Health Services

Industry: Medical/Nursing Services

CEO: Sean Emerson George

Website: http://www.invitae.com

Description: Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Employees: 788